Eli Lilly’s (LLY) “a Great Company,” Says Jim Cramer

Group 1 - Jim Cramer has been frequently discussing Eli Lilly and Company (NYSE: LLY) on his morning show, highlighting the firm's manufacturing initiatives and the potential of its non-weight-loss drug portfolio [2] - Cramer mentioned that Eli Lilly's valuation could reach a trillion dollars, referencing a previous statement by investor Ken Langone when the company's market cap was at 700 billion, and noting its current valuation at 934 billion [2] - The potential of Eli Lilly's GLP-1 weight loss pill is emphasized, with a Citi report suggesting a price target of 1500 dollars, indicating strong market interest and potential for significant growth [2][3] Group 2 - Cramer described Eli Lilly as a "great company," praising CEO Dave Ricks for his leadership and the company's contributions to ALS research [3] - The market is responding positively to Eli Lilly's weight loss pill, with consumer preferences shifting towards pills that can be taken like vitamin supplements, indicating a significant market opportunity [3]